Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...
Available Dexcom CGM products include: Dexcom G6 (adults and children 2 years and older) Dexcom G7 (adults and children 2 ...
DexCom's stock is fairly valued despite positive Q4 2024 results, with muted enthusiasm from Wall Street today. Click here to ...
DexCom (NASDAQ:DXCM – Get Free Report) was upgraded by stock analysts at Robert W. Baird from a “neutral” rating to an ...
Matthew Taylor, an analyst from Jefferies, reiterated the Buy rating on Dexcom (DXCM – Research Report). The associated price target remains ...
In a report released today, Jeff Johnson from Robert W. Baird upgraded Dexcom (DXCM – Research Report) to a Buy, with a price target of ...
Kevin Sayer said at the J.P. Morgan Healthcare Conference that Dexcom also expects to release a 15-day glucose sensor in the ...
DexCom demonstrated strong product demand in third-quarter 2024, highlighted by record new patient starts in its core markets. The flagship G7 and DexCom ONE+ platforms continued to drive adoption ...